US Bancorp DE Lowers Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

US Bancorp DE lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,099 shares of the company’s stock after selling 311 shares during the period. US Bancorp DE’s holdings in Henry Schein were worth $2,429,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. SVB Wealth LLC purchased a new stake in shares of Henry Schein in the fourth quarter valued at $345,000. Versor Investments LP purchased a new stake in Henry Schein during the fourth quarter valued at about $377,000. Proficio Capital Partners LLC purchased a new stake in Henry Schein during the fourth quarter valued at about $943,000. Oppenheimer Asset Management Inc. purchased a new stake in Henry Schein during the fourth quarter valued at about $904,000. Finally, K.J. Harrison & Partners Inc grew its position in Henry Schein by 61.1% during the fourth quarter. K.J. Harrison & Partners Inc now owns 29,000 shares of the company’s stock valued at $1,988,000 after acquiring an additional 11,000 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of a number of research reports. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Trading Up 2.1 %

NASDAQ:HSIC opened at $72.96 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The business’s 50-day simple moving average is $74.44 and its 200 day simple moving average is $72.51. The stock has a market cap of $9.06 billion, a price-to-earnings ratio of 30.02, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the firm posted $0.66 EPS. The company’s revenue was up 5.8% compared to the same quarter last year. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.